Poor Response to Checkpoint Immunotherapy in Uveal Melanoma Highlights the Persistent Need for Innovative Regional Therapy Approaches to Manage Liver Metastases

SIMPLE SUMMARY: Uveal melanoma is a cancer that develops from melanocytes in the eye. This disease is extremely rare and has a strong predilection for liver metastasis, which has a poor long-term prognosis with overall survival of 6 months and 1 year mortality of 80%. Immunotherapy and checkpoint in...

Descripción completa

Detalles Bibliográficos
Autores principales: Szeligo, Brett M., Ivey, Abby D., Boone, Brian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307800/
https://www.ncbi.nlm.nih.gov/pubmed/34298647
http://dx.doi.org/10.3390/cancers13143426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307800/
https://www.ncbi.nlm.nih.gov/pubmed/34298647
http://dx.doi.org/10.3390/cancers13143426

Ejemplares similares